Rocky Mountain Cancer Centers - Boulder /ID# 223723 — Boulder, Colorado

Rocky Mountain Cancer Centers - Boulder /ID# 223723 is a clinical research site located in Boulder, Colorado, United States 80303.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Rocky Mountain Cancer Centers - Boulder /ID# 223723 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Myelodysplastic Syndrome (MDS).

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rocky Mountain Cancer Centers - Boulder /ID# 223723?

Rocky Mountain Cancer Centers - Boulder /ID# 223723 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rocky Mountain Cancer Centers - Boulder /ID# 223723 conducted?

Rocky Mountain Cancer Centers - Boulder /ID# 223723 has 1 clinical trials on record, with 1 currently active. Their work covers Myelodysplastic Syndrome (MDS).

Is Rocky Mountain Cancer Centers - Boulder /ID# 223723 accredited by Crixeo Health?

Rocky Mountain Cancer Centers - Boulder /ID# 223723 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rocky Mountain Cancer Centers - Boulder /ID# 223723?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.